GSK
890 hedge funds and large institutions have $11.1B invested in GSK in 2023 Q4 according to their latest regulatory filings, with 126 funds opening new positions, 269 increasing their positions, 343 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 842 → 890 (+48)
0.3% more ownership
Funds ownership: 6.98% → 7.28% (+0.3%)
22% less repeat investments, than reductions
Existing positions increased: 269 | Existing positions reduced: 343
Holders
890
Holding in Top 10
13
Calls
$227M
Puts
$104M
Top Buyers
| 1 | +$354M | |
| 2 | +$119M | |
| 3 | +$92.3M | |
| 4 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$79.8M |
| 5 |
AC
Armistice Capital
New York
|
+$70.8M |
Top Sellers
| 1 | -$164M | |
| 2 | -$111M | |
| 3 | -$45M | |
| 4 |
Millennium Management
New York
|
-$43.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$39.5M |